Patent · US Active

Compounds for the treatment of metabolic disorders

US8178675B2 · kind B2 · utility

5Cited by

13References

3Claims

0Family size

Assignee

Wellstat Therapeutics Corporation · US

Inventors

Fedor Romantsev · Gaithersburg, US
Shalini Sharma · Gaithersburg, US
Reid W. von Borstel · Potomac, US
Stephen D. Wolpe · Arlington, US

Key dates

Filing date	Nov 9, 2006
Grant date	May 15, 2012
Priority date	—
Expiry date	Mar 14, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyper-lipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed as Formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.